Loading
Gynaecological oncologist at the Medical University of Vienna and ABCSG Vice-President, known for work on breast cancer and hereditary cancer risk.
Christian Singer is Vice-President of the Austrian Breast & Colorectal Cancer Study Group and heads the breast health centre at the Medical University of Vienna's Department of Obstetrics and Gynaecology. His research covers breast cancer treatment, BRCA-associated hereditary breast and ovarian cancer, and translational biomarker studies within ABCSG trials.
| Title | Journal | Year |
|---|---|---|
| Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34) | European Journal of Cancer | 2020 |
| Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial | Nature Cancer | 2025 |
| Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients | Journal of Experimental & Clinical Cancer Research | 2023 |
Shares Austrian Breast & Colorectal Cancer Study Group, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares Journal of experimental & clinical cancer research and the tags leadership, clinician-scientist.
Shares Ovarian cancer, HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.
Shares HR-positive / HER2-negative breast cancer and the tags leadership, clinician-scientist, breast cancer.